%PDF-1.4
%
41 0 obj
<>
endobj
38 0 obj
<>
endobj
110 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-05-11T17:02:10Z
2024-03-29T07:21:21-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T07:21:21-07:00
application/pdf
Heather
2003-304.june
uuid:362b0e83-1dd2-11b2-0a00-2f0927edca00
uuid:362b0e86-1dd2-11b2-0a00-380000000000
endstream
endobj
27 0 obj
<>
endobj
28 0 obj
<>
endobj
42 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 13 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 15 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 17 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 19 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 21 0 R/Type/Page>>
endobj
128 0 obj
[132 0 R]
endobj
129 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6303 0.7762 -0.7762 0.6303 16.7778 46.0632 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 1 K
/GS1 gs
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2004; 31:6)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(1210)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.09 396.47 -10.83 re
f*
0.5 w
109.25 59.09 396.47 -10.83 re
S
BT
0 0 0 1 k
/GS1 gs
/T1_2 1 Tf
-0.00011 Tc 10 0 0 10 54 713.1616 Tm
(REFERENCES)Tj
/T1_3 1 Tf
0.02499 Tw 8 0 0 8 61 703.1616 Tm
[(1.)-875.1 (Fishman D, Faulds G, Jef)17.7 (fery R, et al. )17.7 (The ef)17.7 (fect of novel )]TJ
1.675 -1.25 Td
(polymorphisms in the interleukin-6 \(IL-6\) gene on IL-6 )Tj
0 -1.25 TD
(transcription and plasma IL-6 levels, and an association with)Tj
T*
(systemic-onset juvenile chronic arthritis. J Clin Invest)Tj
0 Tc 0 Tw T*
(1998;102:1369-76.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(2.)-875.1 (Crawley E, Kay R, Sillibourne J, Patel P)110.7 (, Hutchinson I, )17.7 (W)79.9 (oo P)110.8 (.)]TJ
1.675 -1.25 Td
[(Polymorphic haplotypes of the interleukin-10 5\325)-201.1 (flanking region)]TJ
T*
(determine variable interleukin-10 transcription and are associated)Tj
T*
[(with particular phenotypes of juvenile rheumatoid arthritis. )54.8 (Arthritis)]TJ
0 Tc T*
[(Rheum 1999;42:1)36.9 (101-8.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (Date )36.8 (Y)128.9 (, Seki N, Kamizono S, et al. Identification of a genetic risk)]TJ
1.675 -1.25 Td
(factor for systemic juvenile rheumatoid arthritis in the 5\325-flanking)Tj
T*
[(region of the )17.7 (TNF-alpha gene and HLA)-220.2 (genes. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1999;42:2577-82.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(4.)-875.1 (Epplen C, Rumpf H, )54.8 (Albert E, Haas P)110.7 (,)-0.1 ( )17.7 (T)35 (ruckenbrodt H, Epplen JT)73.9 (.)]TJ
1.675 -1.25 Td
(Immunoprinting excludes many potential susceptibility genes as)Tj
T*
(predisposing to early onset pauciarticular juvenile chronic arthritis)Tj
T*
[(except HLA)-220.2 (class II and )17.7 (TNF)79.7 (. Eur J Immunogenet 1995;22:31)36.8 (1-22.)]TJ
-1.675 -1.25 Td
[(5.)-875.1 (Zeggini E, )17.7 (Thomson )17.7 (W)91.8 (, Kwiatkowski D, Richardson )54.8 (A, Ollier )17.7 (W)91.9 (,)]TJ
1.675 -1.25 Td
(Donn R. Linkage and association studies of single-nucleotide )Tj
T*
(polymorphism-tagged tumor necrosis factor haplotypes in juvenile)Tj
T*
[(oligoarthritis. )54.8 (Arthritis Rheum 2002;46:3304-1)36.8 (1.)]TJ
31.325 27.671 Td
[(6.)-875.1 (McDowell )17.7 (TL, Symons JA, Ploski R, Forre O, Duf)17.7 (f GW)91.7 (. )54.8 (A)-220.1 (genetic)]TJ
1.675 -1.25 Td
(association between juvenile rheumatoid arthritis and a novel )Tj
T*
[(interleukin-1 alpha polymorphism. )54.8 (Arthritis Rheum 1995;38:221-8.)]TJ
-1.675 -1.25 Td
[(7.)-875.1 (Donn RP)110.7 (, Barrett JH, Farhan )54.8 (A, et al. Cytokine gene )]TJ
1.675 -1.25 Td
(polymorphisms and susceptibility to juvenile idiopathic arthritis.)Tj
T*
[(British Paediatric Rheumatology Study Group. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2001;44:802-10.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(8.)-875.1 (Donn RP)110.7 (, Farhan )54.8 (AJ, Barrett JH, )17.7 (Thomson )17.7 (W)91.8 (,)-0.1 ( )17.7 (W)79.9 (orthington J, Ollier)]TJ
1.675 -1.25 Td
[(WE. )54.8 (Absence of association between interleukin 1 alpha and)]TJ
T*
(oligoarticular juvenile chronic arthritis in UK patients.)Tj
T*
(Rheumatology Oxford 1999;38:171-5.)Tj
-1.675 -1.25 Td
[(9.)-875.1 (Ozen S, )54.8 (Alikasifoglu M, Bakkaloglu )54.8 (A, et al. )17.7 (T)35 (umour necrosis)]TJ
1.675 -1.25 Td
[(factor alpha G\321>A)-220.2 (-238 and G\321>A)-220.2 (-308 polymorphisms in )]TJ
T*
(juvenile idiopathic arthritis. Rheumatology Oxford 2002;41:223-7.)Tj
-2.175 -1.25 Td
[(10.)-875.1 (Pociot F)79.7 (,)-0.1 ( Molvig J, )17.7 (W)79.9 (ogensen L, )17.7 (W)79.9 (orsaae H, Nerup J. )54.8 (A)-202.3 (T)69.9 (aqI )]TJ
2.175 -1.25 Td
(polymorphism in the human interleukin-1 beta \(IL-1 beta\) gene)Tj
T*
(correlates with IL-1 beta secretion in vitro. Eur J Clin Invest)Tj
0 Tc 0 Tw T*
(1992;22:396-402.)Tj
-0.00011 Tc 0.02499 Tw -2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (V)110.8 (encovsky J, Jarosova K, Ruzickova S, et al. Higher frequency of)]TJ
2.1381 -1.25 Td
(allele 2 of the interleukin-1 receptor antagonist gene in patients)Tj
T*
[(with juvenile idiopathic arthritis. )54.8 (Arthritis Rheum 2001;44:2387-91.)]TJ
ET
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
119.868 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
21 0 obj
<>stream
8;Z\5>8"e,#itt$j>r;1/=VstOk(&.S[$]OJHZfg/JPo+@bA"`BohBC^R"WF=gN$!
Ks$T$[V2mNNY;JgG%/2(/p6+Ubg^.jV_cKC52r/g/rZpQCRY:YB$2r&Xj4u;OB;SXM$;S!^sP#//Y2g$t%)J(#:Uu,b&p3EgJT9nu=
U_<>%FY(MtE3U8MESI1iBEI6Z',3r-Qp0&mZ$ACg?:ad"bKgML&
8!*%]`6!SNVm
endstream
endobj
25 0 obj
[/Indexed/DeviceRGB 255 24 0 R]
endobj
24 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
99 0 obj
<>
endobj
45 0 obj
<>
endobj
61 0 obj
<>
endobj
49 0 obj
<>
endobj
88 0 obj
<>
endobj
115 0 obj
<>
endobj
48 0 obj
<>
endobj
78 0 obj
<>stream
H|T Piӝ!hBGhPQa\`((#Dș8#*rȍYq!x̨%^5#K;f~v[fjwvkz}
q\NR_):^cWk??ae;ggXr!\HyB(EHsRR^3;W+C
XqXۡQnL5&jUA35.Jo\rkT4FaUmTu&^mU>WS
Z9OgPFs8cctd197oFa
N8
NbKg0̄aY8Va'0Z0,#F`$vcxww+UUH y~8N$R֔Ϸm` 'X&NbI'$&l-5F{M䙓&ߞ2}J&IdvډJåSnZ?mveBCQRzS
T4AjYe}H }K/ٻ&X[
D#1|*TÊ!xM_*Zz~K&c0BR᱁ eIye
:>h3T/@-?s>ѿT!
PSms'J6+
Li
Mvʐ2
hv^jɴ6EJĕWgsd27ř"#Zn-1O r@~A@o$>%r>~3#J_04rGrBJ$+AZpȳm4ү=2X z҃n
%R"{HG%Gkrg}x&"l|| 2Du3
8a3E/WFCh-P/T5:/+%nu>ޏ5hG.&Dp')?@s-5̀K9!(E%V\b6